Kuros Biosciences Ag Stock Today
| CSBTF Stock | USD 27.34 4.34 18.87% |
Performance7 of 100
| Odds Of DistressLess than 9
|
Kuros Biosciences is trading at 27.34 as of the 8th of January 2025. This is a 18.87 percent increase since the beginning of the trading day. The stock's lowest day price was 26.4. Kuros Biosciences has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 9th of December 2024 and ending today, the 8th of January 2025. Click here to learn more.
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It has collaboration with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. The company has 36.54 M outstanding shares. More on Kuros Biosciences AG
Moving against Kuros Pink Sheet
Kuros Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Kuros Biosciences AG [CSBTF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 70.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kuros Biosciences's market, we take the total number of its shares issued and multiply it by Kuros Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kuros Biosciences classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 36.54 M outstanding shares.
Kuros Biosciences AG has accumulated about 28.62 M in cash with (5.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.87.
Check Kuros Biosciences Probability Of Bankruptcy
Ownership AllocationKuros Biosciences maintains a total of 36.54 Million outstanding shares. Kuros Biosciences AG holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kuros Ownership Details
Kuros Biosciences Risk Profiles
| Mean Deviation | 2.85 | |||
| Semi Deviation | 3.56 | |||
| Standard Deviation | 5.36 | |||
| Variance | 28.76 |
Kuros Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kuros Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Kuros Biosciences Corporate Management
| Philippe Saudan | Chief Scientific Officer and VP | Profile | |
| BSc BS | CEO Director | Profile | |
| Florence Groot | Head Devel | Profile | |
| Oliver Kronenberg | Legal Counsel | Profile | |
| MS DO | VP Affairs | Profile | |
| Christopher Fair | Chief Officer | Profile | |
| MBA MBA | Chief Officer | Profile |
Other Information on Investing in Kuros Pink Sheet
Kuros Biosciences financial ratios help investors to determine whether Kuros Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kuros with respect to the benefits of owning Kuros Biosciences security.